Lingegowda Selanere Mangala

Instructor

  • 5108 Citations
  • 37 h-Index
19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Lingegowda Selanere Mangala is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Small Interfering RNA Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Growth Medicine & Life Sciences
Tumors Chemical Compounds
Therapeutics Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

  • 5108 Citations
  • 37 h-Index
  • 98 Article
  • 5 Comment/debate
  • 4 Chapter
  • 2 Review article

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors

Gunaratne, P. H., Pan, Y., Rao, A. K., Lin, C., Hernandez-Herrera, A., Liang, K., Rait, A. S., Venkatanarayan, A., Benham, A. L., Rubab, F., Kim, S. S., Rajapakshe, K., Chan, C. K., Mangala, L. S., Lopez, G., Sood, A. K., Rowat, A. C., Coarfa, C., Pirollo, K. F., Flores, E. R. & 1 others, Chang, E. H., Jul 15 2019, In : Cancer. 125, 14, p. 2409-2422 14 p.

Research output: Contribution to journalArticle

Open Access
MicroRNAs
Neoplasms
B-Cell Lymphoma
Therapeutics
Heterografts

Author Correction: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (Nature, (2014), 512, 7515, (431-435), 10.1038/nature13375)

Krzeszinski, J. Y., Wei, W., Huynh, H. D., Jin, Z., Wang, X., Chang, T. C., Xie, X. J., He, L., Mangala, L. S., Lopez, G., Sood, A. K., Mendell, J. T. & Wan, Y., Jun 20 2019, In : Nature. 570, 7761, p. E51

Research output: Contribution to journalComment/debate

Open Access
Osteogenesis
Osteoporosis
History
Neoplasm Metastasis
Bone and Bones

GnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition

Ma, S., Pradeep, S., Villar-Prados, A., Wen, Y., Bayraktar, E., Mangala, L. S., Kim, M. S., Wu, S., Hu, W., Rodriguez-Aguayo, C., Leuschner, C., Liang, X., Ram, P., Schlacher, K., Coleman, R. & Sood, A. K., May 1 2019, In : Molecular cancer therapeutics. 18, 5, p. 969-979 11 p.

Research output: Contribution to journalArticle

Gonadotropin-Releasing Hormone
Ovarian Neoplasms
Peptides
Protein Array Analysis
Comet Assay

Identifying and targeting angiogenesis-related microRNAs in ovarian cancer

Chen, X., Mangala, L. S., Mooberry, L., Bayraktar, E., Dasari, S. K., Ma, S., Ivan, C., Court, K. A., Rodriguez-Aguayo, C., Bayraktar, R., Raut, S., Sabnis, N., Kong, X., Yang, X., Lopez, G., Lacko, A. G. & Sood, A. K., Aug 15 2019, In : Oncogene. 38, 33, p. 6095-6108 14 p.

Research output: Contribution to journalArticle

MicroRNAs
Ovarian Neoplasms
Neoplasms
CD36 Antigens
Vascular Endothelial Growth Factor A
3 Citations (Scopus)

PRKRA/PACT expression promotes chemoresistance of mucinous ovarian cancer

Hisamatsu, T., McGuire, M., Wu, S., Rupaimoole, R., Pradeep, S., Bayraktar, E., Noh, K., Hu, W., Hansen, J. M., Lyons, Y. A., Gharpure, K. M., Nagaraja, A. S., Mangala, L. S., Mitamura, T., Rodriguez-Aguayo, C., Eun, Y. G., Rose, J., Bartholomeusz, G., Ivan, C., Lee, J-S. & 5 others, Matsuo, K., Frumovitz, M., Wong, K. K., Lopez, G. & Sood, A. K., Jan 1 2019, In : Molecular cancer therapeutics. 18, 1, p. 162-172 11 p.

Research output: Contribution to journalArticle

oxaliplatin
Ovarian Neoplasms
Small Interfering RNA
Platinum
Phosphotransferases